| Primary |
| Epilepsy |
30.9% |
| Convulsion |
19.4% |
| Product Used For Unknown Indication |
19.4% |
| Tuberous Sclerosis |
4.2% |
| Drug Use For Unknown Indication |
3.6% |
| Febrile Convulsion |
3.6% |
| Grand Mal Convulsion |
3.0% |
| Complex Partial Seizures |
2.4% |
| Seizures |
2.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
1.8% |
| Convulsion Prophylaxis |
1.2% |
| Immunosuppression |
1.2% |
| Lennox-gastaut Syndrome |
1.2% |
| Partial Seizures |
1.2% |
| Seizure |
1.2% |
| Asthenia |
0.6% |
| Clonic Convulsion |
0.6% |
| Cystitis |
0.6% |
| Depression |
0.6% |
| Diarrhoea |
0.6% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
23.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
7.8% |
| Human Herpesvirus 6 Infection |
6.3% |
| Overdose |
6.3% |
| Toxicity To Various Agents |
6.3% |
| Drug Exposure During Pregnancy |
4.7% |
| Hepatic Adenoma |
4.7% |
| Stevens-johnson Syndrome |
4.7% |
| Thrombocytopenia |
4.7% |
| Completed Suicide |
3.1% |
| Drug Ineffective |
3.1% |
| Drug Toxicity |
3.1% |
| Growth Retardation |
3.1% |
| Hyperammonaemic Encephalopathy |
3.1% |
| Inappropriate Antidiuretic Hormone Secretion |
3.1% |
| Peritonitis Sclerosing |
3.1% |
| Rash Erythematous |
3.1% |
| Vanishing Bile Duct Syndrome |
3.1% |
| Cardio-respiratory Arrest |
1.6% |
| Coma |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
29.0% |
| Epilepsy |
13.8% |
| Convulsion |
11.8% |
| Status Epilepticus |
10.3% |
| Drug Abuse |
10.0% |
| Drug Use For Unknown Indication |
6.0% |
| Infantile Spasms |
3.4% |
| Foetal Exposure During Pregnancy |
3.2% |
| Ill-defined Disorder |
1.9% |
| Grand Mal Convulsion |
1.7% |
| Depression |
1.5% |
| Lennox-gastaut Syndrome |
1.4% |
| Drug Exposure During Pregnancy |
1.0% |
| Tonic Convulsion |
0.8% |
| Insomnia |
0.7% |
| Cough |
0.7% |
| Irritability |
0.7% |
| Pyrexia |
0.7% |
| Meningitis |
0.7% |
| Seizures |
0.7% |
|
| Toxicity To Various Agents |
16.1% |
| Drug Ineffective |
11.4% |
| Completed Suicide |
6.8% |
| Drug Hypersensitivity |
5.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.9% |
| Status Epilepticus |
5.5% |
| Drug Toxicity |
5.1% |
| Maternal Exposure During Pregnancy |
5.1% |
| Death |
4.2% |
| Drug Abuse |
3.8% |
| Weight Decreased |
3.8% |
| Overdose |
3.4% |
| Stillbirth |
3.4% |
| Suicide Attempt |
3.4% |
| Convulsion |
3.0% |
| Vomiting |
3.0% |
| Rash |
2.5% |
| Stevens-johnson Syndrome |
2.5% |
| Syncope |
2.5% |
| Tremor |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.6% |
| Convulsion |
19.2% |
| Epilepsy |
15.8% |
| Drug Use For Unknown Indication |
7.7% |
| Hypertension |
4.0% |
| Status Epilepticus |
3.0% |
| Grand Mal Convulsion |
2.6% |
| Pain |
2.6% |
| Infantile Spasms |
2.5% |
| Depression |
2.5% |
| Osteoporosis |
2.3% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Anxiety |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Schizophrenia |
1.3% |
| Partial Seizures |
1.2% |
| Insomnia |
1.1% |
| Prophylaxis |
1.1% |
| Sleep Disorder |
1.1% |
| Hypothyroidism |
1.0% |
|
| Convulsion |
13.0% |
| Vomiting |
9.2% |
| Weight Decreased |
9.0% |
| Drug Ineffective |
7.9% |
| Stevens-johnson Syndrome |
6.7% |
| Weight Increased |
6.7% |
| Status Epilepticus |
6.3% |
| Somnolence |
6.1% |
| Tremor |
4.3% |
| Death |
3.8% |
| Toxicity To Various Agents |
3.6% |
| Pneumonia |
3.2% |
| Vision Blurred |
3.2% |
| Petit Mal Epilepsy |
2.9% |
| Pyrexia |
2.7% |
| Completed Suicide |
2.5% |
| Respiratory Failure |
2.3% |
| White Blood Cell Count Decreased |
2.3% |
| Myocardial Infarction |
2.0% |
| Nausea |
2.0% |
|
| Interacting |
| Status Epilepticus |
25.9% |
| Epilepsy |
25.1% |
| Convulsion |
10.4% |
| Product Used For Unknown Indication |
9.2% |
| Grand Mal Convulsion |
5.2% |
| Partial Seizures |
4.0% |
| Psychotic Disorder |
3.6% |
| Drug Use For Unknown Indication |
3.2% |
| Hypercholesterolaemia |
2.4% |
| Immunosuppressant Drug Therapy |
2.4% |
| Constipation |
1.6% |
| Atrial Fibrillation |
0.8% |
| Complex Partial Seizures |
0.8% |
| Ear Infection |
0.8% |
| Generalized Tonic-clonic Seizure |
0.8% |
| Hypothyroidism |
0.8% |
| Induction Of Anaesthesia |
0.8% |
| Medical Diet |
0.8% |
| Prophylaxis |
0.8% |
| Renal Transplant |
0.8% |
|
| Hyperammonaemic Encephalopathy |
30.2% |
| Epilepsy |
11.3% |
| Drug Interaction |
7.5% |
| Somnolence |
7.5% |
| Drug Level Decreased |
5.7% |
| Immunosuppressant Drug Level Decreased |
3.8% |
| Lethargy |
3.8% |
| Pyrexia |
3.8% |
| Renal Function Test Abnormal |
3.8% |
| Weight Decreased |
3.8% |
| Depressed Level Of Consciousness |
1.9% |
| Drug Level Increased |
1.9% |
| Gait Disturbance |
1.9% |
| Hyperammonaemia |
1.9% |
| Hypothyroidism |
1.9% |
| Inhibitory Drug Interaction |
1.9% |
| Oedema |
1.9% |
| Off Label Use |
1.9% |
| Potentiating Drug Interaction |
1.9% |
| Renal Failure Acute |
1.9% |
|
